Market Cap 41.16M
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,000
Avg Vol 4,038
Day's Range N/A - N/A
Shares Out 48.43M
Stochastic %K 0%
Beta N/A
Analysts Strong Buy
Price Target $3.00

Company Profile

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. Its customers include hospital outpatient wound care clinics and other private practice physicians treating chronic wo...

Industry: Biotechnology
Sector: Healthcare
Phone: 346 396 4770
Address:
8285 El Rio, Suite 190, Houston, United States
Latest News on AURX
No data available.